Xarelto
These highlights do not include all the information needed to use XARELTO safely and effectively. See full prescribing information for XARELTO. XARELTO (rivaroxaban) tablets, for oral use XARELTO (rivaroxaban) for oral suspension Initial U.S. Approval: 2011
d0e105f6-28f3-45ee-83bd-7d458835242b
HUMAN PRESCRIPTION DRUG LABEL
Aug 31, 2023
Cardinal Health 107, LLC
DUNS: 118546603
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
rivaroxaban
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
rivaroxaban
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
rivaroxaban
Product Details
FDA regulatory identification and product classification information